Adenovirus type 5 vector based ebola virus disease vaccine
重组埃博拉病毒病疫苗（腺病毒载体）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameAdenovirus type 5 vector based ebola virus disease vaccine
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2017/11/16
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTianjin Cansino Biotechnology IncAcademy Of Military Medical Sciences
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesInstitute of Bioengineering Academy of Military Medical Sciences Chinese People's Liberation ArmyTianjin Cansino Biotechnology Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A